CHEST: Nerandomilast Slows Decline in FVC in Idiopathic Pulmonary Fibrosis
No significant difference seen in composite end point of acute exacerbation, hospitalization for respiratory cause, or death
HEPA Purifiers Do Not Reduce Viral Exposures in Classrooms
Classroom samples had an average of three different respiratory viruses, with HEPA filters tied to slightly lower viral diversity
CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With...
20 percent greater mortality benefit seen in obstructive sleep apnea population
Deep Sedation in ICU Linked to Loss of Independent Living
High proportion of time in deep sedation linked to loss of independent living among patients who lived independently before ICU admission
CHEST: SGLT2 Inhibitors May Slow Nodule Growth in Pulmonary Malignancies
Patients prescribed SGLT2 inhibitors less likely to exhibit nodule growth and to undergo a surgical intervention
World Trade Center Toxic Exposure Tied to Higher Risk for Lung Cancer
Greater exposure from Sept. 11, 2001, attacks tied to three times higher rate of disease incidence
Inhaler-Related Emissions Increased 24 Percent From 2014 to 2024
87 percent of total emissions were accounted for by albuterol, budesonide-formoterol, fluticasone propionate inhalers
FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
Twice-daily oral tablet marks first approval of idiopathic pulmonary fibrosis in more than 10 years
Medicaid Expansion Can Improve Five-Year Survival in Cancer
Improvements in cause-specific and overall survival seen for those residing in rural and high-poverty communities
Sotatercept Reduces Risk for Clinical Worsening in Adults With Recently Diagnosed PAH
Benefit with sotatercept seen among adults with pulmonary arterial hypertension diagnosed less than a year earlier
